Diaz-Mitoma Francisco

Avg. Two Year Performance

(6%) Avg. Purchase Return
(3%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)16%10%156%(6%)
Purchase Success Rate2 of 52 of 53 of 52 of 51 of 5
Average Sale Return----------
Sale Success Rate----------

Vbi Vaccines Inc/bc

Drugs » Biotechnology

Chief Medical Officer:

Holdings: 420.24K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--